Review
Published on 27 Jan 2025
Research progress of circRNAs in bone-related diseases
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1481322
Type at least 3 characters
2,947 articles
Articles
Systematic Review
Published on 24 Jan 2025
Research progress and perspectives on the application of tyramide signal amplification-based multiplex immunohistochemistry/immunofluorescence: a bibliometrics analysis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1473414
- 151 views
Review
Published on 23 Jan 2025
Interactions between key genes and pathways in prostate cancer progression and therapy resistance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1467540
- 178 views
Original Research
Accepted on 21 Jan 2025
Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1502405
Original Research
Published on 21 Jan 2025
MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1523068
- 458 views
Original Research
Accepted on 17 Jan 2025
Analysis of the Prognostic Value of Thyroglobulin Antibody Change Trends During Follow-up After 131 I Treatment in Patients with Differentiated Thyroid Carcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1496594
Correction
Published on 17 Jan 2025
Corrigendum: ATG5 and ATG7 expression levels are reduced in cutaneous melanoma and regulated by NRF1
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1549776
- 104 views
Review
Published on 15 Jan 2025
Unveiling hotspots of emerging research in the miRNA-related mechanism underlying cancer through comprehensive bibliometric analysis with implications for precision medicine and non-invasive diagnostics
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1521251
- 222 views
Review
Published on 14 Jan 2025
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1514120
- 507 views
Original Research
Published on 13 Jan 2025
The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1527226
- 235 views
Original Research
Published on 13 Jan 2025
Serum stromal cell-derived factor 1α as a prognostic indicator in elderly patients with acute myeloid leukemia receiving CAG-based chemotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1521179
- 266 views
Review
Accepted on 10 Jan 2025
CircRNAs in Colorectal Cancer: Potential Roles, Clinical Applications, and Natural Product-Based Regulation
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1525779
Clinical Trial
Published on 09 Jan 2025
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1515387
- 316 views
Review
Published on 09 Jan 2025
Copper in the colorectal cancer microenvironment: pioneering a new era of cuproptosis-based therapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1522919
- 199 views
Original Research
Accepted on 07 Jan 2025
Adeno-associated virus mediated artificial circular RNA for triggering cancer immunotherapy to treat prostate cancer
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1443571
Review
Published on 07 Jan 2025
REV7: a small but mighty regulator of genome maintenance and cancer development
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2024.1516165
- 360 views